Back to the overview
Lecture

Regulatory Exclusivity Update in Europe and the USA and the Interplay with IP Strategy

Life Science Strategy Summit on IP & Exclusivity, panel presentation, October 2024, Munich, together with representatives from Cooley, UCB, and Polpharma Biologics

Download as PDF
IP, Media & Technology
Patent Law
Download as PDF

Contact persons

Dr. Manja Epping
Munich

Related articles

10-18-2025
Impulsvortrag zu Guten Forschungsbedingungen als Grundlage für Investments
07-23-2025
Vertragsgestaltung in den Life Sciences
07-15-2025
Rechtliche Herausforderungen: NIS 2, DORA und Co.
05-08-2025
The Transparency Tightrope: Balancing Innovation, Regulation, and IP Protection in a New Era
03-05-2025
Cyber Resilience Act in der Energiespeicherindustrie
01-23-2025
Neues EU-Digitalrecht – Überblick über DA, DGA, AIA und CRA
01-15-2025
Heuking x elevateHer – Neues zu Tracking Tools, KI und Co.
01-01-2025
Hacker ante Portas: IT-Sicherheitsanforderungen NIS2 und DORA: Chancen und Herausforderungen
12-04-2024
Cyber Resilience Act: Bürokratiemonster oder Innovationstreiber?
11-08-2024
KI-Tools in der Patentarbeit
01-15-2024
Patentstreitigkeiten in der Praxis
11-30-2023
KI-Tools für Patentabteilungen

You are currently using an outdated and no longer supported browser (Internet Explorer). To ensure the best user experience and save you from possible problems, we recommend that you use a more modern browser.